Zions Bancorporation N.A. increased its stake in Relx Plc (NYSE:RELX - Free Report) by 44.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 41,256 shares of the technology company's stock after acquiring an additional 12,621 shares during the period. Zions Bancorporation N.A.'s holdings in Relx were worth $1,958,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in RELX. Venturi Wealth Management LLC raised its stake in Relx by 0.9% in the third quarter. Venturi Wealth Management LLC now owns 24,164 shares of the technology company's stock worth $1,147,000 after buying an additional 214 shares in the last quarter. Ballentine Partners LLC boosted its holdings in Relx by 1.4% in the third quarter. Ballentine Partners LLC now owns 17,306 shares of the technology company's stock worth $821,000 after purchasing an additional 240 shares during the last quarter. Marshall Financial Group LLC boosted its holdings in Relx by 0.8% in the third quarter. Marshall Financial Group LLC now owns 30,515 shares of the technology company's stock worth $1,448,000 after purchasing an additional 246 shares during the last quarter. LVW Advisors LLC boosted its holdings in Relx by 1.7% in the second quarter. LVW Advisors LLC now owns 15,189 shares of the technology company's stock worth $697,000 after purchasing an additional 248 shares during the last quarter. Finally, Traveka Wealth LLC raised its position in Relx by 4.5% in the second quarter. Traveka Wealth LLC now owns 6,115 shares of the technology company's stock worth $281,000 after acquiring an additional 264 shares during the period. 15.02% of the stock is currently owned by hedge funds and other institutional investors.
Relx Price Performance
Shares of RELX stock traded down $1.50 during trading hours on Friday, reaching $44.45. 1,485,074 shares of the stock were exchanged, compared to its average volume of 873,219. Relx Plc has a 12-month low of $36.46 and a 12-month high of $48.91. The company's 50-day moving average price is $47.38 and its 200-day moving average price is $45.87.
Analyst Upgrades and Downgrades
Several brokerages have recently commented on RELX. StockNews.com began coverage on shares of Relx in a research report on Wednesday, October 30th. They set a "hold" rating on the stock. Citigroup upgraded shares of Relx to a "strong-buy" rating in a research report on Tuesday, September 17th.
Check Out Our Latest Analysis on RELX
Relx Company Profile
(
Free Report)
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.
Read More
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.